在记忆门诊患者中定义预测长期进展为痴呆的Centiloid量表阈值:[18F]氟比他班淀粉样蛋白PET研究
研究纳入160例非痴呆受试者,进行[18F]氟比他班Aβ-PET,视觉评估按厂商推荐,SUVr按GAAIN指南转换为Centiloid。98例随访至痴呆诊断或临床稳定中位6年后,Centiloid=26预测痴呆的总体预测值87%(NPV=85%,PPV=88%)。视觉评估对应Centiloid=40,预测值86%(NPV=81%,PPV=92%),特异度更高而灵敏度更低。
要点
- Centiloid阈值26对PET后6年进展为痴呆的总体预测值为87%。
- 视觉评估对应Centiloid=40,预测值86%,特异度更高而灵敏度更低。
- 仅随访2年的患者纳入后PPV降至67%,反映短期随访中阳性者多未进展。
核心结论
- Centiloid阈值26可最佳预测PET后6年进展为痴呆,视觉评估提供相似预测值,但特异度更高、灵敏度更低。
研究设计与样本
- 单中心[18F]氟比他班Aβ-PET研究,纳入160例年龄54-86岁的非痴呆受试者;98例随访至痴呆诊断或临床稳定中位6年(最短4.0年,最长8.0年),25例短随访(中位2.0年,最短0.8年,最长3.9年)和37例无随访被排除。
主要发现
- 98例长随访者中,Centiloid=26的总体预测值为87%(NPV=85%,PPV=88%)。
- 视觉评估对应Centiloid=40,预测痴呆的总体预测值为86%(NPV=81%,PPV=92%)。
- 纳入25例仅随访2年的患者后,PPV降至67%(NPV=88%),反映短期随访中许多阳性病例未进展为痴呆。
关键数值与推荐
- Centiloid=26预测PET后6年进展为痴呆的总体预测值为87%(NPV=85%,PPV=88%)。
- 视觉评估对应Centiloid=40,预测痴呆的总体预测值为86%(NPV=81%,PPV=92%)。
- 纳入仅随访2年的25例患者后,PPV=67%(NPV=88%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究为单中心设计。
- 37例无随访被排除,25例仅随访2年(中位2.0年)被排除。
- 仅随访2年的患者纳入后PPV降至67%,反映短期随访中许多阳性病例未进展为痴呆。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate cerebral amyloid-β(Aβ) pathology in older adults with cognitive complaints, visual assessment of PET images is approved as the routine method for image interpretation. In research studies however, Aβ-PET semi-quantitative measures are associated with greater risk of progression to dementia; but until recently, these measures lacked standardization. Therefore, the Centiloid scale, providing standardized Aβ-PET semi-quantitation, was recently validated. We aimed to determine the predictive values of visual assessments and Centiloids in non-demented patients, using long-term progression to dementia as our standard of truth. METHODS: One hundred sixty non-demented participants (age, 54-86) were enrolled in a monocentric [18F] flutemetamol Aβ-PET study. Flutemetamol images were interpreted visually following the manufacturers recommendations. SUVr values were converted to the Centiloid scale using the GAAIN guidelines. Ninety-eight persons were followed until dementia diagnosis or were clinically stable for a median of 6 years (min = 4.0; max = 8.0). Twenty-five patients with short follow-up (median = 2.0 years; min = 0.8; max = 3.9) and 37 patients with no follow-up were excluded. We computed ROC curves predicting subsequent dementia using baseline PET data and calculated negative (NPV) and positive (PPV) predictive values. RESULTS: In the 98 participants with long follow-up, Centiloid = 26 provided the highest overall predictive value = 87% (NPV = 85%, PPV = 88%). Visual assessment corresponded to Centiloid = 40, which predicted dementia with an overall predictive value = 86% (NPV = 81%, PPV = 92%). Inclusion of the 25 patients who only had a 2-year follow-up decreased the PPV = 67% (NPV = 88%), reflecting the many positive cases that did not progress to dementia after short follow-ups. CONCLUSION: A Centiloid threshold = 26 optimally predicts progression to dementia 6 years after PET. Visual assessment provides similar predictive value, with higher specificity and lower sensitivity. TRIAL REGISTRATION: Eudra-CT number: 2011-001756-12.
引用
- Hanseeuw BJ, Malotaux V, Dricot L, et al. Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study. Eur J Nucl Med Mol Imaging. 2020. PMID: 32601802. doi:10.1007/s00259-020-04942-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。